A question is “what are the optimal targets for anticoagulant therapies?”

by Nobuyuki Yokoyama, Shunsuke Takaki, Masashi Yokose, Kaori Kuwabara, Akiko Anzai, Takako Hamada, Shizuka Kashiwagi, Kenta Okamura, Yoh Sugawara, Takahisa Goto
Published 2020-02-01

Thrombomodulin in disseminated intravascular coagulation and other critical conditions—a multi-faceted anticoagulant protein with therapeutic potential

by Takashi Ito, Jecko Thachil, Hidesaku Asakura, Jerrold H. Levy, Toshiaki Iba
Published 2019-08-01

Risk factors and treatments for disseminated intravascular coagulation in neonates

by Hayato Go, Hitoshi Ohto, Kenneth E. Nollet, Nozomi Kashiwabara, Kei Ogasawara, Mina Chishiki, Shun Hiruta, Ichiri Sakuma, Yukihiko Kawasaki, Mitsuaki Hosoya
Published 2020-04-01

Human Soluble Recombinant Thrombomodulin, ART-123, Resolved Early Phase Coagulopathies, but Did Not Significantly Alter the 28 Day Outcome in the Treatment of DIC Associated with I...

by Shusuke Mori, Tomohiko Ai, Toshiki Sera, Kanae Ochiai, Yasuhiro Otomo
Published 2019-09-01